@manpritaurora
With only 2- 3 people in R&D, how are they having somany number 1 one brands and also able to make NDS like oral azacitidine and difficult to make products like albumin bound paclitaxel ? Doesnt add up.
But on the other hand, doing CRO for other oncology companies like Intaas, shilpa, Natco etc do give some comfort regarding their capablities and stated numbers.
Would be helpful if you can summarize any new insights gained post AGM.
Subscribe To Our Free Newsletter |